Cargando…
Medicines for long-term obesity management
Obesity is always genetic or epigenetic in origin in an obesogenic environment. Dietary therapy is required for weight loss. Drugs to suppress hunger and increase satiety may assist while losing weight and are essential for most patients in the weight maintenance period. A combination of drugs may b...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081949/ https://www.ncbi.nlm.nih.gov/pubmed/35592363 http://dx.doi.org/10.18773/austprescr.2022.009 |
_version_ | 1784703104520814592 |
---|---|
author | Proietto, Joseph |
author_facet | Proietto, Joseph |
author_sort | Proietto, Joseph |
collection | PubMed |
description | Obesity is always genetic or epigenetic in origin in an obesogenic environment. Dietary therapy is required for weight loss. Drugs to suppress hunger and increase satiety may assist while losing weight and are essential for most patients in the weight maintenance period. A combination of drugs may be needed. A personalised approach must be used when selecting the appropriate weight loss drug for the patient. This considers possible contraindications, the method of administration and adverse effects, and includes discussing the cost of the treatment. Several drugs do not have an approved indication in Australia for weight loss. |
format | Online Article Text |
id | pubmed-9081949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | NPS MedicineWise |
record_format | MEDLINE/PubMed |
spelling | pubmed-90819492022-05-18 Medicines for long-term obesity management Proietto, Joseph Aust Prescr Article Obesity is always genetic or epigenetic in origin in an obesogenic environment. Dietary therapy is required for weight loss. Drugs to suppress hunger and increase satiety may assist while losing weight and are essential for most patients in the weight maintenance period. A combination of drugs may be needed. A personalised approach must be used when selecting the appropriate weight loss drug for the patient. This considers possible contraindications, the method of administration and adverse effects, and includes discussing the cost of the treatment. Several drugs do not have an approved indication in Australia for weight loss. NPS MedicineWise 2022-04-01 2022-04 /pmc/articles/PMC9081949/ /pubmed/35592363 http://dx.doi.org/10.18773/austprescr.2022.009 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Article Proietto, Joseph Medicines for long-term obesity management |
title | Medicines for long-term obesity management |
title_full | Medicines for long-term obesity management |
title_fullStr | Medicines for long-term obesity management |
title_full_unstemmed | Medicines for long-term obesity management |
title_short | Medicines for long-term obesity management |
title_sort | medicines for long-term obesity management |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081949/ https://www.ncbi.nlm.nih.gov/pubmed/35592363 http://dx.doi.org/10.18773/austprescr.2022.009 |
work_keys_str_mv | AT proiettojoseph medicinesforlongtermobesitymanagement |